In order to accomplish reliable and valid research into the characteristics and mechanisms of Alzheimer's disease (AD) and related dementias, it is imperative to have data available from a well- characterized cohort of patients, with longitudinal follow-up to provide information on the course of the disease. The cohort should have a broad range of levels of education and socioeconomic status, as well as racial diversity. The cohort should contain patients with varying levels of disease severity, in order to provide subjects for studies requiring mild, moderate, or severe AD. Further, a system must be in place for the prospective entry of new patients and age-equivalent control subjects into a registry to be available for future research studies. The Clinical Core of the Alzheimer's Disease Research Center fulfills these functions for the University of Pittsburgh ADRC. The purpose of this Clinical Core is to provide evaluation and follow-up to patients and control subjects enrolled through the Memory Disorders Clinic and followed in the ADRC Registry. Specifically, the Core provides a detailed evaluation of all patients/control subjects at study entry, and annual re-evaluations until the patient/subject drops from the project or dies. The Core also strives towards maximal participation in the autopsy program of the ADRC by providing longitudinal follow-up to these patients and control subjects. The Clinical Core is also responsible for providing clinical data, research subjects (patients and controls), and technical and scientific leadership for support of new and ongoing research at the University of Pittsburgh ADRC and associated local, regional, national, and international studies. Finally, the ADRC will continue outreach programs developed during the past three years to provide care and support for members of the medically underserved inner-city and rural populations of Western Pennsylvania. The ADRC established a satellite clinic, the Alzheimer Outreach Center, in the predominantly African American Hill District of Pittsburgh during the current funding period. Patients seen in the AOC Clinic evaluated and enrolled in the ADRC Registry in the same manner as the patients at the University Memory Disorders Clinic, increasing the number of African American controls and patients in the Registry. Special programs to educate the African American Community on the value of autopsy are part of this program. External confirmation of the accuracy of the clinical diagnosis of AD is vital to assure that the diagnostic procedures employed by the Clinical Core are appropriate. Autopsy confirmation of a clinical diagnosis of Probable AD was greater than 90% for all cases from the ADRC coming to autopsy since inception of the Center.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Specialized Center (P50)
Project #
3P50AG005133-16S1
Application #
6098022
Study Section
Project Start
1999-08-01
Project End
2000-04-30
Budget Start
1998-10-01
Budget End
1999-09-30
Support Year
16
Fiscal Year
1999
Total Cost
Indirect Cost
Name
University of Pittsburgh
Department
Type
DUNS #
053785812
City
Pittsburgh
State
PA
Country
United States
Zip Code
15213
Haaksma, Miriam L; Calderón-Larrañaga, Amaia; Olde Rikkert, Marcel G M et al. (2018) Cognitive and functional progression in Alzheimer disease: A prediction model of latent classes. Int J Geriatr Psychiatry 33:1057-1064
Kamboh, M Ilyas (2018) A Brief Synopsis on the Genetics of Alzheimer's Disease. Curr Genet Med Rep 6:133-135
Ramsey, Christine M; Gnjidic, Danijela; Agogo, George O et al. (2018) Longitudinal patterns of potentially inappropriate medication use following incident dementia diagnosis. Alzheimers Dement (N Y) 4:1-10
La Joie, Renaud; Ayakta, Nagehan; Seeley, William W et al. (2018) Multisite study of the relationships between antemortem [11C]PIB-PET Centiloid values and postmortem measures of Alzheimer's disease neuropathology. Alzheimers Dement :
Rodakowski, Juleen; Reynolds 3rd, Charles F; Lopez, Oscar L et al. (2018) Developing a Non-Pharmacological Intervention for Individuals With Mild Cognitive Impairment. J Appl Gerontol 37:665-676
Pottier, Cyril; Zhou, Xiaolai; Perkerson 3rd, Ralph B et al. (2018) Potential genetic modifiers of disease risk and age at onset in patients with frontotemporal lobar degeneration and GRN mutations: a genome-wide association study. Lancet Neurol 17:548-558
Hadjichrysanthou, Christoforos; McRae-McKee, Kevin; Evans, Stephanie et al. (2018) Potential Factors Associated with Cognitive Improvement of Individuals Diagnosed with Mild Cognitive Impairment or Dementia in Longitudinal Studies. J Alzheimers Dis 66:587-600
Ritzel, Rodney M; Lai, Yun-Ju; Crapser, Joshua D et al. (2018) Aging alters the immunological response to ischemic stroke. Acta Neuropathol 136:89-110
Hanfelt, John J; Peng, Limin; Goldstein, Felicia C et al. (2018) Latent classes of mild cognitive impairment are associated with clinical outcomes and neuropathology: Analysis of data from the National Alzheimer's Coordinating Center. Neurobiol Dis 117:62-71
Cohen, Ann D; McDade, Eric; Christian, Brad et al. (2018) Early striatal amyloid deposition distinguishes Down syndrome and autosomal dominant Alzheimer's disease from late-onset amyloid deposition. Alzheimers Dement 14:743-750

Showing the most recent 10 out of 667 publications